1. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005;90:916-20.
2. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. The Lancet 1992;339:280-2.
3. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönleinpurpura in adults: outcome and prognostic factors. J Am SocNephrol 2002;13:1271-8.
4. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. The Lancet 2002;360:666-70.
5. García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA. Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 2002;32:149-56.
6. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53.
7. Yokoyama H. Clinical manifestations of Henoch–Schönlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2016;20:552-60.
8. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria For Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010;69:798-806.
9. Stanley F. Lo. Reference intervals for laboratory tests and procedures. In: Behrman RE, Kliegman RM, Stanton BF, Geme JW, Schor NF, editors. Nelson Textbook of Pediatrics. 20th ed. Philadephia: Elsevier; 2015. p. 3464-73.
10. Kratz A, Pesce MA, Basner RC, Einstein AJ. Laboratory Values of Clinical Importance. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 19ed. New York: McGraw-Hill; 2014. p. 2754-64.
11. Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schönlein purpura: comparison between adults and children. Pediatr Neonatol 2009;50:162-8.
12. Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura. J Korean Med Sci 2014;29:198-203.
13. Veraldi S, Mancuso R, Rizzitelli G, Gianotti R, Ferrante P. Henoch-Schonlein syndrome associated with human Parvovirus B19 primary infection. Eur J Dermatol 1999;9:232-3.
14. Saulsbury FT. Henoch-Schonlein Purpura in Children: Report of 100 Patients and Review of the Literature. Medicine 1999;78:395-409.
15. Drago F, Arditi MR, Rebora A. Henoch‐Schönlein purpura induced by fluoroquinolones. Br J Dermatol 1994;131:448.
16. Borrás-Blasco J, Enriquez R, Amoros F, Cabezuelo JB, Navarro-Ruiz A, Pérez M, et al. Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature. IntJ Clin Pharmacol Ther 2003;41:213-6.
17. Blanco R, González-Gay MA, Ibáñez D, Alba C, Pérez de Llano LA. Henoch-Schönlein purpura as a clinical presentation of small cell lung cancer. ClinExpRheumatol 1997;15:545-7.
18. Zickerman AM, Allen AC, Talwar V, Olczak SA, Brownlee A, Holland M, et al. IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis 2000;36:E19.1-5.
19. Garcias VA, Herr HW. Henoch-Schonlein purpura associated with cancer of prostate. Urology 1982;19:155-8.
20. Blanco P, Denisi R, Rispal P, Deminière C, Pellegrin JL, Leng B, et al. Henoch-Schönlein purpura associated with segmental and focal proliferative glomerulonephritis in a patient with Hodgkin's disease. Nephrol Dial Transplant 1999;14:179-80.
21. Day C, Savage CO, Jones EL, Cockwell P. Henoch‐Schönlein nephritis and non‐Hodgkin's lymphoma. Nephrol Dial Transplant 2001;16:1080-1.
22. Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL. Clinical manifestations and outcomes of Henoch-Schönlein purpura: comparison between adults and children. PediatrNeonatol 2009;50:162-8.
23. Goldstein , Amanda R, et al. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992;1. 339:280-2.
24. Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999;13:816-23.
25. Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, and Rodriguez-Ledo P, et al. Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001;80:279-90.
26. Butani L, Morgenstern BZ. Long-term outcome in children after Henoch-Schonlein purpura nephritis. Clin Pediatr 2007;46:505-11.
27. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 2002;360:666-70.
28. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002;13:1271-8.
29. Rosanna Coppo, Simeone Andrulli, Alessandro Amore, Bruno Gianoglio, Giovanni Conti, Licia Peruzzi, et al. Predictors of Outcome in Henoch-Schönlein Nephritis in Children and Adults. Am J Kidney Dis 2006;47:993-1003.
30. Shi Y, Chen W, Jalal D, Li Z, Chen W, Mao H, Yang Q, Johnson RJ, et al. Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res 2012;35:153-60.
31. Calviño MC, Llorca J, García-Porrúa C, Fernández-Iglesias JL, Rodriguez- Ledo P, González-Gay MA. Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine 2001;80:279-90.
32. Trygstad CW, Stiehm ER. Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics 1971;47:1023-8.
33. Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 2001;59:823-34.
34. Motoyama O, Iitaka K. Henoch-Schonleinpurpura with hypocomplementemia in children. PediatrInt 2005;47:39-42.
35. Lin Q, Min Y, Li Y, Zhu Y, Song X, et al. Henoch-Schönlein purpura with hypocomplementemia. PediatrNephrol 2012;27:801-6.
36. Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activityin patients with Henoch-Schönlein purpura. Dermatology 1992;184:171-6.
37. Smith GC, Davidson JE, Hughes DA, Holme E, Beattie TJ. Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol 1997;11:477-80.
38. Kuźma-Mroczkowska E, Pańczyk-Tomaszewska M, Szmigielska A, Szymanik-Grzelak H, Roszkowska-Blaim M. Mycoplasma pneumoniae as a trigger for Henoch-Schönlein purpura in children. Cent Eur J Immunol 2015;40:489-92.